Mechanism of MEK inhibition determines efficacy in mutant KRAS- versus BRAF-driven cancers
Georgia Hatzivassiliou(Gene Therapy Laboratory), Jacob R. Haling, Huifen Chen, Kyung Song, Steve Price, Robert A. Heald, Joanne F. M. Hewitt(Cairn Biosciences (United States)), Mark Zak, Ariana Peck(Novartis (Switzerland)), Christine Orr, Mark Merchant, Klaus P. Hoeflich, Jocelyn Chan, Shiuh-Ming Luoh, Daniel J. Anderson(Novartis Institutes for BioMedical Research), Mary J. C. Ludlam(MRC Mitochondrial Biology Unit), Christian Wiesmann(Novartis (Switzerland)), Mark Ultsch, Lori S. Friedman, Shiva Malek, Marcia Belvin
Cited by 320
Abstract
Related Papers
No related papers found
Powered by citation graph analysis